RUNX2 and ocular melanoma: At day 28, the relative expression levels of osteogenic genes (Alpl, Bglap, and Runx2) for cells grown in OM showed a respective 4, 3.5, and 18 fold increase compared to the non-OM control (Fig. 2D).